Tianda Pharma (00455.HK) announced that its wholly-owned subsidiary, Tianda Medical Technology (Zhuhai), has been issued a drug registration certificate by the National Medical Products Administration for 'Ibuprofen Suspension,' which is considered to have passed consistency evaluation. The product's main ingredient is ibuprofen, which is used to reduce fever caused by common cold or influenza in children, as well as to relieve mild to moderate pain in children such as headache, joint pain, migraine, toothache, muscle pain, and neuralgia.
天大藥業(00455.HK)布洛芬混懸液獲藥品註冊證書
Tianda Pharma (00455.HK) obtained the pharmaceutical registration certificate for Ibuprofen Suspension.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.